Click for best price
Hospitalacquired Infection Diagnostics Market Size, Share 2023
| Market size in 2022 |
US$ 4991.3 million
|
Forecast Market size by 2029 |
US$ 7439.1 million
|
| Growth Rate |
CAGR of 5.9% |
Number of Pages |
69 Pages |
This report aims to provide a comprehensive presentation of the global market for Hospital-acquired Infection Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-acquired Infection Diagnostics. This report contains market size and forecasts of Hospital-acquired Infection Diagnostics in global, including the following market information:
Global Hospital-acquired Infection Diagnostics Market Revenue, 2018-2023, 2024-2032, ($ millions)
Global top five companies in 2022 (%)
The global Hospital-acquired Infection Diagnostics market was valued at US$ 4991.3 million in 2022 and is projected to reach US$ 7439.1 million by 2029, at a CAGR of 5.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Instrument and Reagents Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Hospital-acquired Infection Diagnostics include Abbott Laboratories, Advan DX, Abbott, Astrazeneca PLC, Bayer Schering Pharma LLC, Becton Dickinson And Company, Cepheid Inc., Roche AG and Daiichi Sankyo, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Hospital-acquired Infection Diagnostics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hospital-acquired Infection Diagnostics Market, by Type, 2018-2023, 2024-2032 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Type, 2022 (%)
Instrument and Reagents
Consumables
Global Hospital-acquired Infection Diagnostics Market, by Application, 2018-2023, 2024-2032 ($ millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinics
Ambulatory Surgery Centers (ASC)
Others
Global Hospital-acquired Infection Diagnostics Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions)
Global Hospital-acquired Infection Diagnostics Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hospital-acquired Infection Diagnostics revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Hospital-acquired Infection Diagnostics revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
Advan DX
Abbott
Astrazeneca PLC
Bayer Schering Pharma LLC
Becton Dickinson And Company
Cepheid Inc.
Roche AG
Daiichi Sankyo
Hologic, Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Hospital-acquired Infection Diagnostics, market overview.
Chapter 2: Global Hospital-acquired Infection Diagnostics market size in revenue.
Chapter 3: Detailed analysis of Hospital-acquired Infection Diagnostics company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Hospital-acquired Infection Diagnostics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Hospital-acquired Infection Diagnostics Market, Global Outlook and Forecast 2023-2030 |
| Market size in 2022 |
US$ 4991.3 million
|
| Forecast Market size by 2029 |
US$ 7439.1 million
|
| Growth Rate |
CAGR of 5.9% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
69 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Hospital-acquired Infection Diagnostics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hospital-acquired Infection Diagnostics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hospital-acquired Infection Diagnostics Overall Market Size
2.1 Global Hospital-acquired Infection Diagnostics Market Size: 2022 VS 2030
2.2 Global Hospital-acquired Infection Diagnostics Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Hospital-acquired Infection Diagnostics Players in Global Market
3.2 Top Global Hospital-acquired Infection Diagnostics Companies Ranked by Revenue
3.3 Global Hospital-acquired Infection Diagnostics Revenue by Companies
3.4 Top 3 and Top 5 Hospital-acquired Infection Diagnostics Companies in Global Market, by Revenue in 2022
3.5 Global Companies Hospital-acquired Infection Diagnostics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Players in Global Market
3.6.1 List of Global Tier 1 Hospital-acquired Infection Diagnostics Companies
3.6.2 List of Global Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Hospital-acquired Infection Diagnostics Market Size Markets, 2022 & 2030
4.1.2 Instrument and Reagents
4.1.3 Consumables
4.2 By Type - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
4.2.1 By Type - Global Hospital-acquired Infection Diagnostics Revenue, 2018-2023
4.2.2 By Type - Global Hospital-acquired Infection Diagnostics Revenue, 2024-2030
4.2.3 By Type - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Hospital-acquired Infection Diagnostics Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinics
5.1.4 Ambulatory Surgery Centers (ASC)
5.1.5 Others
5.2 By Application - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
5.2.1 By Application - Global Hospital-acquired Infection Diagnostics Revenue, 2018-2023
5.2.2 By Application - Global Hospital-acquired Infection Diagnostics Revenue, 2024-2030
5.2.3 By Application - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Hospital-acquired Infection Diagnostics Market Size, 2022 & 2030
6.2 By Region - Global Hospital-acquired Infection Diagnostics Revenue & Forecasts
6.2.1 By Region - Global Hospital-acquired Infection Diagnostics Revenue, 2018-2023
6.2.2 By Region - Global Hospital-acquired Infection Diagnostics Revenue, 2024-2030
6.2.3 By Region - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Hospital-acquired Infection Diagnostics Revenue, 2018-2030
6.3.2 US Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.3.3 Canada Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.3.4 Mexico Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Hospital-acquired Infection Diagnostics Revenue, 2018-2030
6.4.2 Germany Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.3 France Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.4 U.K. Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.5 Italy Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.6 Russia Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.7 Nordic Countries Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.4.8 Benelux Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Hospital-acquired Infection Diagnostics Revenue, 2018-2030
6.5.2 China Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.5.3 Japan Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.5.4 South Korea Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.5.5 Southeast Asia Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.5.6 India Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Hospital-acquired Infection Diagnostics Revenue, 2018-2030
6.6.2 Brazil Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.6.3 Argentina Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, 2018-2030
6.7.2 Turkey Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.7.3 Israel Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.7.4 Saudi Arabia Hospital-acquired Infection Diagnostics Market Size, 2018-2030
6.7.5 UAE Hospital-acquired Infection Diagnostics Market Size, 2018-2030
7 Hospital-acquired Infection Diagnostics Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Hospital-acquired Infection Diagnostics Major Product Offerings
7.1.4 Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Advan DX
7.2.1 Advan DX Company Summary
7.2.2 Advan DX Business Overview
7.2.3 Advan DX Hospital-acquired Infection Diagnostics Major Product Offerings
7.2.4 Advan DX Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.2.5 Advan DX Key News & Latest Developments
7.3 Abbott
7.3.1 Abbott Company Summary
7.3.2 Abbott Business Overview
7.3.3 Abbott Hospital-acquired Infection Diagnostics Major Product Offerings
7.3.4 Abbott Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.3.5 Abbott Key News & Latest Developments
7.4 Astrazeneca PLC
7.4.1 Astrazeneca PLC Company Summary
7.4.2 Astrazeneca PLC Business Overview
7.4.3 Astrazeneca PLC Hospital-acquired Infection Diagnostics Major Product Offerings
7.4.4 Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.4.5 Astrazeneca PLC Key News & Latest Developments
7.5 Bayer Schering Pharma LLC
7.5.1 Bayer Schering Pharma LLC Company Summary
7.5.2 Bayer Schering Pharma LLC Business Overview
7.5.3 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Major Product Offerings
7.5.4 Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.5.5 Bayer Schering Pharma LLC Key News & Latest Developments
7.6 Becton Dickinson And Company
7.6.1 Becton Dickinson And Company Company Summary
7.6.2 Becton Dickinson And Company Business Overview
7.6.3 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Major Product Offerings
7.6.4 Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.6.5 Becton Dickinson And Company Key News & Latest Developments
7.7 Cepheid Inc.
7.7.1 Cepheid Inc. Company Summary
7.7.2 Cepheid Inc. Business Overview
7.7.3 Cepheid Inc. Hospital-acquired Infection Diagnostics Major Product Offerings
7.7.4 Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.7.5 Cepheid Inc. Key News & Latest Developments
7.8 Roche AG
7.8.1 Roche AG Company Summary
7.8.2 Roche AG Business Overview
7.8.3 Roche AG Hospital-acquired Infection Diagnostics Major Product Offerings
7.8.4 Roche AG Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.8.5 Roche AG Key News & Latest Developments
7.9 Daiichi Sankyo
7.9.1 Daiichi Sankyo Company Summary
7.9.2 Daiichi Sankyo Business Overview
7.9.3 Daiichi Sankyo Hospital-acquired Infection Diagnostics Major Product Offerings
7.9.4 Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.9.5 Daiichi Sankyo Key News & Latest Developments
7.10 Hologic, Inc.
7.10.1 Hologic, Inc. Company Summary
7.10.2 Hologic, Inc. Business Overview
7.10.3 Hologic, Inc. Hospital-acquired Infection Diagnostics Major Product Offerings
7.10.4 Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue in Global Market (2018-2023)
7.10.5 Hologic, Inc. Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Hospital-acquired Infection Diagnostics Market Opportunities & Trends in Global Market
Table 2. Hospital-acquired Infection Diagnostics Market Drivers in Global Market
Table 3. Hospital-acquired Infection Diagnostics Market Restraints in Global Market
Table 4. Key Players of Hospital-acquired Infection Diagnostics in Global Market
Table 5. Top Hospital-acquired Infection Diagnostics Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Hospital-acquired Infection Diagnostics Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Hospital-acquired Infection Diagnostics Revenue Share by Companies, 2018-2023
Table 8. Global Companies Hospital-acquired Infection Diagnostics Product Type
Table 9. List of Global Tier 1 Hospital-acquired Infection Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Hospital-acquired Infection Diagnostics Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Hospital-acquired Infection Diagnostics Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Hospital-acquired Infection Diagnostics Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Hospital-acquired Infection Diagnostics Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2024-2030
Table 30. Abbott Laboratories Company Summary
Table 31. Abbott Laboratories Hospital-acquired Infection Diagnostics Product Offerings
Table 32. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 33. Abbott Laboratories Key News & Latest Developments
Table 34. Advan DX Company Summary
Table 35. Advan DX Hospital-acquired Infection Diagnostics Product Offerings
Table 36. Advan DX Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 37. Advan DX Key News & Latest Developments
Table 38. Abbott Company Summary
Table 39. Abbott Hospital-acquired Infection Diagnostics Product Offerings
Table 40. Abbott Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 41. Abbott Key News & Latest Developments
Table 42. Astrazeneca PLC Company Summary
Table 43. Astrazeneca PLC Hospital-acquired Infection Diagnostics Product Offerings
Table 44. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 45. Astrazeneca PLC Key News & Latest Developments
Table 46. Bayer Schering Pharma LLC Company Summary
Table 47. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Product Offerings
Table 48. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 49. Bayer Schering Pharma LLC Key News & Latest Developments
Table 50. Becton Dickinson And Company Company Summary
Table 51. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Product Offerings
Table 52. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 53. Becton Dickinson And Company Key News & Latest Developments
Table 54. Cepheid Inc. Company Summary
Table 55. Cepheid Inc. Hospital-acquired Infection Diagnostics Product Offerings
Table 56. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 57. Cepheid Inc. Key News & Latest Developments
Table 58. Roche AG Company Summary
Table 59. Roche AG Hospital-acquired Infection Diagnostics Product Offerings
Table 60. Roche AG Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 61. Roche AG Key News & Latest Developments
Table 62. Daiichi Sankyo Company Summary
Table 63. Daiichi Sankyo Hospital-acquired Infection Diagnostics Product Offerings
Table 64. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 65. Daiichi Sankyo Key News & Latest Developments
Table 66. Hologic, Inc. Company Summary
Table 67. Hologic, Inc. Hospital-acquired Infection Diagnostics Product Offerings
Table 68. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue (US$, Mn) & (2018-2023)
Table 69. Hologic, Inc. Key News & Latest Developments
List of Figures
Figure 1. Hospital-acquired Infection Diagnostics Segment by Type in 2022
Figure 2. Hospital-acquired Infection Diagnostics Segment by Application in 2022
Figure 3. Global Hospital-acquired Infection Diagnostics Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Hospital-acquired Infection Diagnostics Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Hospital-acquired Infection Diagnostics Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Hospital-acquired Infection Diagnostics Revenue in 2022
Figure 8. By Type - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 9. By Application - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 10. By Type - Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 12. By Application - Global Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 14. By Region - Global Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 15. By Country - North America Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 16. US Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 20. Germany Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 21. France Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 28. China Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 32. India Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 34. Brazil Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Hospital-acquired Infection Diagnostics Revenue Market Share, 2018-2030
Figure 37. Turkey Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Hospital-acquired Infection Diagnostics Revenue, (US$, Mn), 2018-2030
Figure 41. Abbott Laboratories Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Advan DX Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Abbott Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Astrazeneca PLC Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Bayer Schering Pharma LLC Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Becton Dickinson And Company Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Cepheid Inc. Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Roche AG Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Daiichi Sankyo Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Hologic, Inc. Hospital-acquired Infection Diagnostics Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
